IRCT20150101020514N22
Not yet recruiting
Phase 2
Safety and efficacy of assessment of Alis collagen drink (containing 4 g hydrolyzed collagen) compared to a control collagen-free drink for improvement of biophysical and ultrasonography skin parameters
Pishgamane Eixire Sabze Arvand Co.0 sites30 target enrollmentTBD
Conditionsskin aging.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- skin aging.
- Sponsor
- Pishgamane Eixire Sabze Arvand Co.
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Ages 35 to 55
- •Healthy people with skin type II to V
- •Signing the consent form for participation in the study
Exclusion Criteria
- •History of using RF, anti aging and intense pulsed light during the past 6 months
- •.Active smoker in last 2 years
- •Pregnancy or lactating
- •Suffering from systemic diseases that affect skin health, such as vascular collagen diseases, diabetes, hypothyroidism, as well as liver and kidney failure.
- •History of taking supplements containing collagen, hyaluronic acid and vitamin C in the last 3 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Evaluation of the safety and feasibility of FSTL-1 cardiac patchIRCT20210827052304N1ational institute for medical search development (NIMAD)9
Recruiting
Not Applicable
Collagenase treatment for ocular burnsCTRI/2021/08/035994Hyderabad Eye Research Foundation
Recruiting
Phase 2
effect of collagenase enzyme in sclerodermaIRCT20140624018210N11Iran University of Medical Sciences17
Completed
Phase 2
Repair of bone fractures with scaffold and stem cellsIRCT20181222042074N1Mashhad University of Medical Sciences10
Unknown
Phase 1
Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin DefectsWoundsDiabetic Foot UlcersBurnsNCT02672280South China Research Center for Stem Cell and Regenerative Medicine30